Gary Bloomgren
Impact in
-
- Multiple Sclerosis Research Studies
- Oncology top 5%
- Polyomavirus and related diseases
Papers in
- Co-authors
- Sandra Richman (8 shared papers)Tatiana Plavina (5 shared papers)Meena Subramanyam (5 shared papers)Sophia Lee (4 shared papers)Carmen M. Bozic (6 shared papers)Rebecca A. Noel (4 shared papers)James V. Scanlon (3 shared papers)Alfred W. Sandrock (3 shared papers)
- Journals
- Drug Safety (2 papers)Annals of Neurology (2 papers)Diabetic Medicine (1 paper)Neurology (1 paper)Diabetes Care (1 paper)
- Partner nations
- United StatesIrelandGermany
In The Last Decade
Gary Bloomgren
16 papers receiving 2.2k citations
Gary Bloomgren's Hit Papers
Peers
Comparison fields: 5 of 63
- Pathology and Forensic Medicine 848
- Oncology 694
- Endocrinology, Diabetes and Metabolism 410
- Toxicology 33
- Genetics 167
Countries citing papers authored by Gary Bloomgren
This map shows the geographic impact of Gary Bloomgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Bloomgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Bloomgren more than expected).
Fields of papers citing papers by Gary Bloomgren
This network shows the impact of papers produced by Gary Bloomgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Bloomgren. The network helps show where Gary Bloomgren may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary Bloomgren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy Hit paper breakdown → | 2012 | 1004 |
| 2 | Increased Risk of Acute Pancreatitis and Biliary Disease Observed in Patients With Type 2 Diabetes Hit paper breakdown → | 2009 | 372 |
| 3 | 2014 | 358 | |
| 4 | 2011 | 125 | |
| 5 | 2011 | 115 | |
| 6 | 2014 | 105 | |
| 7 | 2016 | 103 | |
| 8 | 2015 | 88 | |
| 9 | 2012 | 69 | |
| 10 | 2008 | 22 | |
| 11 | 2012 | 9 | |
| 12 | 2013 | 5 | |
| 13 | 2020 | 5 | |
| 14 | 2012 | 2 | |
| 15 | 2018 | 1 | |
| 16 | 2021 | 1 |
About Gary Bloomgren
Gary Bloomgren is a scholar working on Oncology, Surgery, Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health and Toxicology, having authored 16 papers that have together received 2.4k indexed citations. Recurring topics across this work include Polyomavirus and related diseases (7 papers), Pancreatitis Pathology and Treatment (4 papers), Diabetes Treatment and Management (2 papers), Opioid Use Disorder Treatment (2 papers), Cytomegalovirus and herpesvirus research (1 paper), Schizophrenia research and treatment (1 paper), Pregnancy and Medication Impact (1 paper) and Pharmacovigilance and Adverse Drug Reactions (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (848 citations), Oncology (694 citations), Endocrinology, Diabetes and Metabolism (410 citations), Toxicology (33 citations) and Genetics (167 citations). Gary Bloomgren has collaborated with scholars based in United States, Ireland and Germany. Frequent co-authors include Sandra Richman, Tatiana Plavina, Meena Subramanyam, Sophia Lee, Carmen M. Bozic, Rebecca A. Noel, James V. Scanlon, Alfred W. Sandrock, Ruth E. Patterson and Susan E. Goelz. Their work appears in journals such as Drug Safety, Annals of Neurology, Diabetic Medicine, Neurology and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.